Hodgkin Lymphoma in Adults.

Author: BröckelmannPaul J, EichenauerDennis A, EngertAndreas, FollmannMarkus, JakobTina, SkoetzNicole

Paper Details 
Original Abstract of the Article :
BACKGROUND: Hodgkin lymphoma is the most common neoplasm in young adults, with an incidence of 2 to 3 cases per 100 000 persons per year. Risk-adapted chemotherapy and radiotherapy usually lead to cure. Finding ways to lessen the treatment- associated morbidity and mortality is a major goal of curre...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131364/

データ提供:米国国立医学図書館(NLM)

Hodgkin Lymphoma in Adults: A Comprehensive Guide to Treatment

This guideline provides a comprehensive overview of Hodgkin lymphoma (HL) in adults, encompassing diagnostic evaluation, treatment options, and follow-up care. The authors conducted a systematic literature review to create an updated guideline for the management of HL, drawing on evidence from randomized controlled trials, prospective, and retrospective studies. The guideline aims to offer a clear and evidence-based approach to the treatment of HL, providing clinicians with a valuable resource for informed decision-making.

A Roadmap to Recovery: Navigating Hodgkin Lymphoma Treatment

The guideline outlines a risk-adapted approach to HL treatment, recommending specific treatment strategies based on the stage of the disease. The authors emphasize the importance of positron emission tomography (PET) imaging for diagnostic evaluation and treatment guidance. The guideline highlights the favorable prognosis for HL, with a five-year survival rate of 95%, but also emphasizes the need for careful follow-up to monitor for potential late sequelae.

A Journey Through the Desert of Cancer: Navigating the Complexities of Hodgkin Lymphoma Treatment

This guideline serves as a valuable resource for healthcare professionals navigating the complex landscape of HL treatment. It provides a roadmap for guiding patients through the stages of diagnosis, treatment, and follow-up care. The guideline highlights the importance of personalized treatment approaches and emphasizes the need for ongoing monitoring to address potential long-term effects.

Dr. Camel's Conclusion

This guideline offers a comprehensive and evidence-based approach to the management of Hodgkin lymphoma in adults. It’s like a treasure map guiding clinicians through the desert of HL treatment, helping them to navigate the complexities of diagnosis, treatment, and follow-up care. The guideline underscores the importance of personalized treatment strategies and careful follow-up to ensure optimal outcomes for patients.

Date :
  1. Date Completed 2019-09-30
  2. Date Revised 2019-09-30
Further Info :

Pubmed ID

30149835

DOI: Digital Object Identifier

PMC6131364

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.